Hans Theodor Eich

Summary

Affiliation: University of Cologne
Country: Germany

Publications

  1. ncbi request reprint Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 58:1121-7. 2004
  2. ncbi request reprint Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Strahlenther Onkol 181:378-84. 2005
  3. ncbi request reprint Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 63:860-5. 2005
  4. doi request reprint Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Germany
    Strahlenther Onkol 184:23-9. 2008
  5. ncbi request reprint [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature]
    Hans Theodor Eich
    Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Rontgenpraxis 56:137-44. 2007
  6. ncbi request reprint [A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas]
    H T Eich
    Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Rontgenpraxis 56:145-51. 2007
  7. ncbi request reprint [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology]
    Hans Theodor Eich
    Klinik und Poliklinik für Strahlentherapie der Universität zu Köln, Germany
    Rontgenpraxis 55:114-24. 2003
  8. ncbi request reprint A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 69:1187-92. 2007
  9. ncbi request reprint Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma
    Hans Theodor Eich
    Department of Radiotherapy, University of Cologne, Germany
    Strahlenther Onkol 179:233-40. 2003
  10. ncbi request reprint Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 55:899-906. 2003

Detail Information

Publications42

  1. ncbi request reprint Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 58:1121-7. 2004
    ..The purpose of the present investigation was to assess the feasibility of such a procedure and its impact on the final definition of disease extension and patient treatment...
  2. ncbi request reprint Esthesioneuroblastoma in childhood and adolescence. Better prognosis with multimodal treatment?
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Strahlenther Onkol 181:378-84. 2005
    ..To investigate the influence of radio- and chemotherapy, the treatment and course of the disease in children and adolescents with ENB were analyzed retrospectively...
  3. ncbi request reprint Biophysical analysis of the acute toxicity of radiotherapy in Hodgkin's lymphoma--a comparison between extended field and involved field radiotherapy based on the data of the German Hodgkin Study Group
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 63:860-5. 2005
    ....
  4. doi request reprint Neoadjuvant radiochemotherapy and radical resection for advanced squamous cell carcinoma of the oral cavity. Outcome of 134 patients
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Germany
    Strahlenther Onkol 184:23-9. 2008
    ..After successful phase II trials, the following therapy regimen for resectable advanced oral carcinoma was applied...
  5. ncbi request reprint [Radiotherapy of Graves' ophthalmopathy--state of the art and review of the literature]
    Hans Theodor Eich
    Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Rontgenpraxis 56:137-44. 2007
    ..This article describes the sequences, dosages and fractionation schemes as well as the risks and side effects of the radiotherapy...
  6. ncbi request reprint [A teleradiotherapeutic network for lymphoma patients within the competence network malignant lymphomas]
    H T Eich
    Klinik und Poliklinik für Strahlentherapie, Klinikum der Universität zu Köln, Joseph Stelzmann Str 9, 50924 Köln, Germany
    Rontgenpraxis 56:145-51. 2007
    ....
  7. ncbi request reprint [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology]
    Hans Theodor Eich
    Klinik und Poliklinik für Strahlentherapie der Universität zu Köln, Germany
    Rontgenpraxis 55:114-24. 2003
    ..Actually the GHSG evaluates the efficacy of risk-adapted therapy composed of polychemotherapy (CT) and radiotherapy (RT). An extensive RT quality assurance program has been practiced during the study generations and will be continued...
  8. ncbi request reprint A Contribution to solve the problem of the need for consolidative radiotherapy after intensive chemotherapy in advanced stages of Hodgkin's lymphoma--analysis of a quality control program initiated by the radiotherapy reference center of the German Hodgki
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 69:1187-92. 2007
    ..A quality control program based on a multidisciplinary panel of radiation oncologists, radiologists, and medical oncologists who reviewed all patients' staging and restaging imaging was initiated...
  9. ncbi request reprint Multimodality therapy including radiotherapy and chemotherapy improves event-free survival in stage C esthesioneuroblastoma
    Hans Theodor Eich
    Department of Radiotherapy, University of Cologne, Germany
    Strahlenther Onkol 179:233-40. 2003
    ..To evaluate the efficacy of multimodality therapy in patients with esthesioneuroblastoma (ENB)...
  10. ncbi request reprint Long-term efficacy, curative potential, and prognostic factors of radiotherapy in primary cutaneous B-cell lymphoma
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 55:899-906. 2003
    ..To evaluate the efficacy of RT, patient data from two centers were analyzed and compared with recent reports in the literature...
  11. doi request reprint Quality control of involved field radiotherapy in patients with early-favorable (HD10) and early-unfavorable (HD11) Hodgkin's lymphoma: an analysis of the German Hodgkin Study Group
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 71:1419-24. 2008
    ..20 Gy) within a combined-modality approach. For these patients a central prospective review of all diagnostic imaging was performed by expert radiation oncologists to control disease extension and to define IF treatment volume...
  12. doi request reprint Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin's lymphoma: final analysis of the German Hodgkin Study Group HD11 trial
    Hans Theodor Eich
    University of Cologne, German Hodgkin Study Group, Koln, Germany
    J Clin Oncol 28:4199-206. 2010
    ..It is unclear whether treatment results can be improved with more intensive chemotherapy and which radiation dose needs to be applied...
  13. ncbi request reprint Salvage radiotherapy in patients with relapsed and refractory Hodgkin's lymphoma: a retrospective analysis from the German Hodgkin Lymphoma Study Group
    Andreas Josting
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Str 9, 50924 Cologne, Germany
    J Clin Oncol 23:1522-9. 2005
    ..To evaluate treatment outcome and prognostic factors in patients with refractory or first relapsed Hodgkin's disease (HD) treated with salvage radiotherapy (SRT) alone...
  14. doi request reprint The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Cologne, Germany
    J Craniomaxillofac Surg 41:22-7. 2013
    ..The present study was performed in order to evaluate the prognostic impact of cTNM and ypTNM in oral cancer patients treated with preoperative RCT and resection...
  15. ncbi request reprint Two cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine plus extended-field radiotherapy is superior to radiotherapy alone in early favorable Hodgkin's lymphoma: final results of the GHSG HD7 trial
    Andreas Engert
    First Department of Internal Medicine, Coordination Center for Clinical Trials, and Department of Radiotherapy, University Hospital of Cologne, Cologne, Germany
    J Clin Oncol 25:3495-502. 2007
    ....
  16. doi request reprint Current role and future developments of radiotherapy in early-stage favourable Hodgkin's lymphoma
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Radiotherapy Reference Center of the German Hodgkin Study Group GHSG, Germany
    Strahlenther Onkol 183:16-8. 2007
  17. ncbi request reprint Initiation of a teleradiotherapeutic network for patients in German lymphoma studies
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 58:805-8. 2004
    ..The purpose of this report was to evaluate the feasibility of teleradiotherapy and to describe our experiences with these innovative tools...
  18. doi request reprint Combined-modality treatment in advanced oral squamous cell carcinoma: Primary surgery followed by adjuvant concomitant radiochemotherapy
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Cologne, Germany
    Strahlenther Onkol 187:555-60. 2011
    ..We evaluated our experiences with adjuvant concomitant RCT in advanced OSCC to compare the results with other treatment schemes using adjuvant RCT...
  19. ncbi request reprint Involved-node radiotherapy in early-stage Hodgkin's lymphoma. Definition and guidelines of the German Hodgkin Study Group (GHSG)
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Germany
    Strahlenther Onkol 184:406-10. 2008
    ..The German Hodgkin Study Group aims to compare it with standard IF radiotherapy in their future HD17 trial...
  20. ncbi request reprint The HD12 panel of the German Hodgkin Lymphoma Study Group (GHSG): a quality assurance program based on a multidisciplinary panel reviewing all patients' imaging
    Hans Theodor Eich
    Department of Radiotherapy, University of Cologne, Germany
    Am J Clin Oncol 27:279-84. 2004
    ..Patients with Hodgkin disease receive high-quality CT imaging. A central independent multidisciplinary panel markedly improves quality assurance for these study patients...
  21. doi request reprint ABVD in older patients with early-stage Hodgkin lymphoma treated within the German Hodgkin Study Group HD10 and HD11 trials
    Boris Boll
    German Hodgkin Study Group, Cologne, Germany
    J Clin Oncol 31:1522-9. 2013
    ..ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) chemotherapy is regarded as standard of care in these patients. However, little is known on feasibility and efficacy of ABVD in this age group...
  22. doi request reprint Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma
    Andreas Engert
    Department of Internal Medicine, University of Cologne, Cologne, Germany
    N Engl J Med 363:640-52. 2010
    ....
  23. ncbi request reprint The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel
    Rolf Peter Muller
    Department of Radiation Oncology, University of Cologne, Joseph Stelzmann Strasse 9, 50924 Köln, Germany
    Strahlenther Onkol 181:557-66. 2005
    ..Extensive continuing quality assurance programs (QAPs) during the study generations have been performed. The purpose of the present article is to summarize the experiences and results of the performed and ongoing QAPs...
  24. ncbi request reprint Lymphocyte-rich classical Hodgkin's lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkin's Study Group trials
    Alexander Shimabukuro-Vornhagen
    First Department of Internal Medicine, University Hospital Cologne, Joseph Stelzmann Str 9, 50924 Cologne, Germany
    J Clin Oncol 23:5739-45. 2005
    ..To investigate the clinical characteristics and treatment outcome of patients with lymphocyte-rich classical Hodgkin's lymphoma (LRCHL) compared with other histologic subtypes of Hodgkin's lymphoma (HL)...
  25. ncbi request reprint Phase I/II trial of simultaneous whole-brain irradiation and dose-escalating topotecan for brain metastases
    Martin Kocher
    Department of Radiotherapy, University of Cologne, Joseph Stelzmann Strasse 9, 50924 Köln, Germany
    Strahlenther Onkol 181:20-5. 2005
    ..v. topotecan application simultaneously with whole-brain irradiation (WBRT) was conducted to estimate toxicity, maximum tolerated dose and survival in patients with inoperable brain metastases...
  26. doi request reprint Preoperative vs. postoperative radiochemotherapy in patients with N2 squamous cell carcinoma of the oral cavity
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Germany
    Oral Oncol 48:1019-24. 2012
    ..No studies have been carried out to investigate whether radiochemotherapy should be applied before or after surgery...
  27. doi request reprint Podoplanin expression predicts prognosis in patients with oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Kerpenerstrasse 62, 50937 Cologne, Germany
    Oral Oncol 47:873-8. 2011
    ....
  28. ncbi request reprint Efficacy and toxicity of postoperative temozolomide radiochemotherapy in malignant glioma
    Martin Kocher
    Department of Radiation Oncology, University of Cologne, Koln, Germany
    Strahlenther Onkol 181:157-63. 2005
    ..To evaluate the feasibility, safety and efficacy of daily temozolomide concurrent with postoperative radiotherapy in malignant glioma...
  29. doi request reprint Prognostic impact of different TNM-based stage groupings for oral squamous cell carcinoma
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Cologne, Germany
    Head Neck 33:1467-75. 2011
    ..The purpose of this study was to evaluate the prognostic significance of different TNM-based stage groupings proposed in the literature...
  30. ncbi request reprint Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer
    Robert Semrau
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Int J Radiat Oncol Biol Phys 64:1308-16. 2006
    ..In a subgroup analysis the influence of pretherapeutical hemoglobin level (p-Hb) on survival under locoregional control (SLC) was tested...
  31. doi request reprint Radiotherapy of splenomegaly : a palliative treatment option for a benign phenomenon in malignant diseases
    Jan Kriz
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Strahlenther Onkol 187:221-4. 2011
    ..SM occurs in association with hematologic disorders. The purpose of this analysis was to determine the indication, treatment concepts, and efficiency of RT...
  32. doi request reprint Radiotherapy for early mediastinal Hodgkin lymphoma according to the German Hodgkin Study Group (GHSG): the roles of intensity-modulated radiotherapy and involved-node radiotherapy
    Julia Koeck
    Department of Radiation Oncology, University Medical Center Mannheim, University of Heidelberg, Mannheim, Germany
    Int J Radiat Oncol Biol Phys 83:268-76. 2012
    ....
  33. doi request reprint Neoadjuvant radiochemotherapy and surgery for advanced rectal cancer : prognostic significance of tumor regression
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Strahlenther Onkol 187:225-30. 2011
    ..We retrospectively evaluated the impact of downstaging and tumor regression as prognostic factors and its influence on the ability to perform sphincter-sparing surgery...
  34. doi request reprint Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin's lymphomas treated with radiation therapy
    Hans Theodor Eich
    Department of Radiation Oncology, University of Cologne, Koln, Germany
    Strahlenther Onkol 185:288-95. 2009
    ..Retrospective analysis of therapy results in patients with stage I-II and limited stage III nodal low-grade non-Hodgkin's lymphoma (NHL)...
  35. ncbi request reprint Radiotherapy for giant cell tumors of the bone: a safe and effective treatment modality
    Jan Kriz
    Department of Radiation Oncology, University of Cologne, Cologne, Germany
    Anticancer Res 32:2069-73. 2012
    ..Since the value of RT is not well defined, a national cohort study was conducted...
  36. ncbi request reprint Role of postoperative radiotherapy in the management of Merkel cell carcinoma
    Hans Theodor Eich
    Department of Radiotherapy, University of Cologne, Joseph Stelzmann Strasse 9, D 50924 Cologne, Germany
    Am J Clin Oncol 25:50-6. 2002
    ..Postoperative radiotherapy to the primary tumor region and the regional lymphatics is effective in the prevention of locoregional recurrence. Prospective clinical trials should be performed to confirm these observations...
  37. doi request reprint Prognostic value of the sixth edition of the UICC's TNM classification and stage grouping for oral cancer
    Matthias Kreppel
    Department for Oral and Cranio maxillo and Facial Plastic Surgery, University of Cologne, Cologne, Germany
    J Surg Oncol 102:443-9. 2010
    ..The staging system is under continuous revision. The aim of our study was to assess the prognostic value of the UICC sixth edition for oral cancer, which was established in 2003...
  38. ncbi request reprint Evolution of radiation therapy within the German Hodgkin Study Group trials
    Hans Theodor Eich
    Department of Radiation Oncology, University of Munster, Germany
    J Natl Compr Canc Netw 9:1073-80. 2011
    ....
  39. pmc Neoadjuvant chemoradiation in squamous cell carcinoma of the maxillary sinus: a 26-year experience
    Matthias Kreppel
    Department of Oral and Cranio Maxillo and Facial Plastic Surgery, University of Cologne, Kerpener Straße 62, 50931 Cologne, Germany Center of Integrated Oncology CIO Cologne Bonn, Kerpener Straße 62, 50931 Cologne, Germany
    Chemother Res Pract 2012:413589. 2012
    ..Neoadjuvant radiochemotherapy followed by radical surgery is an effective treatment for patients with advanced maxillary sinus squamous cell carcinoma. In terms of treatment response cisplatin seems to be more effective than carboplatin...
  40. ncbi request reprint Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group
    K Behringer
    First Department of Internal Medicine, University Hospital Cologne, German Hodgkin Lymphoma Study Group GHSG
    Ann Oncol 15:1079-85. 2004
    ..The aim of this retrospective analysis was to assess the incidence, relative risk and risk factors of secondary solid tumors in HD patients registered in the database of the German Hodgkin Lymphoma Study Group (GHSG)...
  41. ncbi request reprint Acral erythrodysesthesia syndrome caused by intravenous infusion of docetaxel in breast cancer
    Dorothee Eich
    Department of Dermatology, University of Cologne, University of Cologne, Germany
    Am J Clin Oncol 25:599-602. 2002
    ..We propose here that these characteristic histologic features are essential in the differentiation from fixed drug eruption and localized graft-versus-host disease...
  42. ncbi request reprint Radiotherapy does not influence the severe pulmonary toxicity observed with the administration of gemcitabine and bleomycin in patients with advanced-stage Hodgkin's lymphoma treated with the BAGCOPP regimen: a report by the German Hodgkin's Lymphoma Stud
    Andrew Macann
    Department of Radiation Oncology, Auckland Regional Cancer and Blood Service, Auckland, New Zealand
    Int J Radiat Oncol Biol Phys 70:161-5. 2008
    ....